Cancer Family
Intestinal Neoplasm
CI-CAN-00000209Explore in graph →
Non-malignant1,893 active trials21 approved drugs383 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000209Explore in graph →
Clinical trials
9,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02280070 | RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301). | unknown | Phase 2 | 110 | Clinical Research Support Center KyushOTHER | 1 | Oct 31, 2014 | clinicaltrials |
| NCT02268006 | IMRT-SIB and Capecitabine in Preoperative Rectal Cancer Treatment(BISER) | unknown | Phase 2 | 50 | Institute of Oncology LjubljanaOTHER | 1 | Oct 20, 2014 | clinicaltrials |
| NCT02216487 | Trial of FOLF(HA)Iri With Cetuximab in mCRC(Chime) | unknown | Phase 2 | 45 | Western General Hospital, AustraliaOTHER | 1 | Aug 29, 2014 | clinicaltrials |
| NCT00410462 | Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma | unknown | Phase 2 | 118 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Aug 8, 2014 | clinicaltrials |
| NCT02177084 | Percutaneous Tibial Nerve Stimulation in the Treatment of Anterior Resection Syndrome After Rectal Cancer Surgery | unknown | Phase 2 | 12 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jun 27, 2014 | clinicaltrials |
| NCT02128425 | FOLFOXIRI Compared to FOLFOX in First Line Treatment of Metastatic Colorectal Cancer | unknown | Phase 2 | 162 | Sun Yat-sen UniversityOTHER | 1 | May 7, 2014 | clinicaltrials |
| NCT02117557 | Safety Study of Transumbilical Single Incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer | unknown | Phase 2 | 198 | Guoxin LiOTHER | 1 | Apr 21, 2014 | clinicaltrials |
| NCT02066688 | Study of Folic Acid, Calcium and Vitamin D in Preventing Colorectal Polyps and Colorectal Cancer | unknown | Phase 2 / Phase 3 | 2,400 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Feb 20, 2014 | clinicaltrials |
| NCT01426490 | The Effects of Vitamin B-6 Status on Homocysteine, Oxidative Stress, One-carbon Metabolism and Methylation: Cross-section, Case-control, Intervention and Follow-up Studies in Colorectal Cancer | unknown | Phase 2 / Phase 3 | 300 | Taichung Veterans General HospitalOTHER | 1 | Feb 19, 2014 | clinicaltrials |
| NCT01880658 | Phase II Study of Maintenance Capecitabine to Treat Resectable Colorectal Cancer(CAMCO) | unknown | Phase 2 | 100 | Sun Yat-sen UniversityOTHER | 1 | Feb 11, 2014 | clinicaltrials |
| NCT00553683 | Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer | unknown | Phase 1 / Phase 2 | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00795301 | A Study of Radiotherapy in Rectal Cancer Using Oxaliplatin, Capecitabine With or Without Cetuximab | unknown | Phase 2 | 74 | National University Hospital, SingaporeOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00967655 | Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer | unknown | Phase 2 | 54 | Loma Linda Oncology Medical Group, Inc.OTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT01067053 | Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients.(BECOX) | unknown | Phase 2 | 69 | Grupo Espanol Multidisciplinario del Cancer DigestivoOTHER | 1 | Jan 9, 2014 | clinicaltrials |
| NCT00027833 | Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer | unknown | Phase 2 | — | Herbert Irving Comprehensive Cancer CenterOTHER | 2 | Jan 6, 2014 | clinicaltrials |
| NCT02027363 | Maintenance Treatment With Capecitabine in Colorectal Cancer Patients | unknown | Phase 2 | 245 | Sun Yat-sen UniversityOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT02022852 | Neoadjuvant Sequential Therapy in Locally Advanced Mid/Low Rectal Cancer | unknown | Phase 2 | 80 | Harbin Medical UniversityOTHER | 1 | Dec 30, 2013 | clinicaltrials |
| NCT00408551 | Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver | unknown | Phase 2 | 20 | Goshen Health SystemOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00031616 | NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer | unknown | Phase 1 / Phase 2 | — | NewBioticsINDUSTRY | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00852228 | Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy(OPTILIV) | unknown | Phase 2 | 60 | Association pour la Recherche sur le Temps Biologique et la ChronothérapieOTHER | 4 | Dec 12, 2013 | clinicaltrials |
| NCT00005877 | Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer | unknown | Phase 2 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT01529164 | Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer | unknown | Phase 2 | 51 | Chinese Academy of Medical SciencesOTHER | 1 | Nov 27, 2013 | clinicaltrials |
| NCT00007826 | Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer | unknown | Phase 1 / Phase 2 | — | OnyvaxINDUSTRY | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00625625 | Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer | unknown | Phase 2 | 225 | Saint John's Cancer InstituteOTHER | 0 | Sep 17, 2013 | clinicaltrials |
| NCT01110785 | Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer | unknown | Phase 2 | 46 | Leiden University Medical CenterOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT01929499 | Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon Cancer(CIKCC) | unknown | Phase 2 | 210 | Yanjuan ZhuOTHER | 1 | Aug 29, 2013 | clinicaltrials |
| NCT00669812 | High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma | unknown | Phase 2 | 60 | Cancer Research UKOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01586117 | A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity | unknown | Phase 2 | 40 | Chinese Academy of Medical SciencesOTHER | 1 | Aug 15, 2013 | clinicaltrials |
| NCT00974389 | S-1 and Bevacizumab in Treating Patients With Colorectal Cancer That is Recurrent or Cannot Be Removed by Surgery | unknown | Phase 2 | 40 | Osaka Medical CollegeOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01097265 | Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery | unknown | Phase 2 / Phase 3 | 1,500 | Jeroen Bosch ZiekenhuisOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01190462 | Cetuximab and Simvastatin in Treating Patients With Advanced or Metastatic Colorectal Cancer | unknown | Phase 2 | 51 | Leiden University Medical CenterOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01899118 | Nimotuzumab in Combination With Chemoradiation in Patients With Locally Advanced Rectal Cancer | unknown | Phase 2 | 50 | Zhejiang Cancer HospitalOTHER | 1 | Jul 15, 2013 | clinicaltrials |
| NCT01839539 | Study of DC-CIK to Treat Colorectal Cancer | unknown | Phase 2 | 60 | Guangxi Medical UniversityOTHER | 1 | Apr 25, 2013 | clinicaltrials |
| NCT01832948 | Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer | unknown | Phase 2 | 30 | Zhejiang Cancer HospitalOTHER | 1 | Apr 16, 2013 | clinicaltrials |
| NCT01826396 | Standard and High Dose Irinotecan Based on UGT1A1 Genotype for First-line Treatment of Locally Advanced Colon Cancer | unknown | Phase 2 | 100 | Colorectal Cancer Institute of the Heilongjiang Academy of Medical SciencesOTHER | 1 | Apr 8, 2013 | clinicaltrials |
| NCT01811277 | SOX Sequential S-1 in Advanced Biliary Tract Carcinoma(BTC)and Pancreatic Cancer | unknown | Phase 2 | 40 | Peking UniversityOTHER | 1 | Mar 15, 2013 | clinicaltrials |
| NCT01763450 | Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer | unknown | Phase 2 | 100 | Liaoning Cancer Hospital & InstituteOTHER | 1 | Jan 29, 2013 | clinicaltrials |
| NCT01320319 | Effect of EPA on Aerobic Performance, Muscle, and Quality of Life in Colorectal Cancer Surgery Patients(EPA-colo) | unknown | Phase 2 / Phase 3 | 70 | University of NottinghamOTHER | 1 | Dec 4, 2012 | clinicaltrials |
| NCT01736904 | wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients | unknown | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Nov 29, 2012 | clinicaltrials |
| NCT01227239 | Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting | unknown | Phase 1 / Phase 2 | 45 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Nov 27, 2012 | clinicaltrials |
| NCT01655641 | Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery(TMGS) | unknown | Phase 2 / Phase 3 | 118 | Tribhuvan University Teaching Hospital, Institute Of Medicine.OTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT01237665 | IXO (Irinotecan, Xeloda, Oxaliplatin) in Rectal Cancer(IXOr) | unknown | Phase 2 | 15 | Ottawa Hospital Research InstituteOTHER | 1 | Oct 15, 2012 | clinicaltrials |
| NCT01679327 | Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer | unknown | Phase 2 | 100 | Chinese Academy of Medical SciencesOTHER | 1 | Sep 6, 2012 | clinicaltrials |
| NCT01384994 | Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients | unknown | Phase 2 | 111 | PD Dr. med. Volker HeinemannOTHER | 1 | Jul 9, 2012 | clinicaltrials |
| NCT01591798 | Efficacy Study of Robotic Surgery for Rectal Cancer | unknown | Phase 2 | 146 | National Cancer Center, KoreaOTHER_GOV | 1 | May 7, 2012 | clinicaltrials |
| NCT01552967 | Efficacy and Safety Study of a Modified XELOX Regimen in First-Line Treatment of Metastatic Colorectal Adenocarcinoma(mXELOX) | unknown | Phase 2 | 30 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT00689702 | Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer(XERT) | unknown | Phase 2 | 43 | Institute of Oncology LjubljanaOTHER | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00842686 | Preoperative Radiotherapy With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer: CRAB Phase II Study(CRAB) | unknown | Phase 2 | 60 | Institute of Oncology LjubljanaOTHER | 1 | Mar 26, 2012 | clinicaltrials |
| NCT01064999 | A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer | unknown | Phase 2 / Phase 3 | 240 | Fudan UniversityOTHER | 1 | Mar 14, 2012 | clinicaltrials |
| NCT00122291 | A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer | unknown | Phase 2 | 66 | Alberta Health servicesOTHER | 1 | Jan 19, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Oct 31, 2014source: clinicaltrials